16 Einträge gefunden

1. Epithelial splicing regulatory protein 1 and 2 (ESRP1 and ESRP2) upregulation predicts poor prognosis in prostate cancer

   1. Freytag, Morton
   2. Kluth, Martina
   3. Bady, Elena
   4. Hube-Magg, Claudia
   5. Makrypidi-Fraune, Georgia
   6. Heinzer, Hans
   7. Höflmayer, Doris

   2020 - Forschungsinformationssystem des UKE
2. Increased Cytoplasmic CD138 Expression Is Associated with Aggressive Characteristics in Prostate Cancer and Is an Independent Predictor for Biochemical Recurrence

   1. Kind, Simon
   2. Kluth, Martina
   3. Hube-Magg, Claudia
   4. Möller, Katharina
   5. Makrypidi-Fraune, Georgia
   6. Lutz, Florian
   7. Lennartz, Maximilian

   2020 - Forschungsinformationssystem des UKE
3. High B7-H3 expression is linked to increased risk of prostate cancer progression

   1. Bonk, Sarah
   2. Tasdelen, Pinar
   3. Kluth, Martina
   4. Hube-Magg, Claudia
   5. Makrypidi-Fraune, Georgia
   6. Möller, Katharina
   7. Höflmayer, Doris

   2020 - Forschungsinformationssystem des UKE
4. High BCAR1 expression is associated with early PSA recurrence in ERG negative prostate cancer

   1. Heumann, Asmus
   2. Heinemann, Nina
   3. Hube-Magg, Claudia
   4. Lang, Dagmar S
   5. Grupp, Katharina
   6. Kluth, Martina
   7. Minner, Sarah

   2018 - Forschungsinformationssystem des UKE - frei zugänglich
5. Cytoplasmic accumulation of ELAVL1 is an independent predictor of biochemical recurrence associated with genomic instability in prostate cancer

   1. Melling, Nathaniel
   2. Taskin, B
   3. Hube-Magg, Claudia
   4. Kluth, Martina
   5. Minner, Sarah
   6. Koop, Christina
   7. Grob, Tobias

   2016 - Forschungsinformationssystem des UKE
6. Reduced AZGP1 expression is an independent predictor of early PSA recurrence and associated with ERG-fusion positive and PTEN deleted prostate cancers

   1. Burdelski, Christoph
   2. Kleinhans, Sandra
   3. Kluth, Martina
   4. Hube-Magg, Claudia
   5. Minner, Sarah
   6. Koop, Christina
   7. Graefen, Markus

   2016 - Forschungsinformationssystem des UKE
7. The prognostic value of SUMO1/Sentrin specific peptidase 1 (SENP1) in prostate cancer is limited to ERG-fusion positive tumors lacking PTEN deletion

   1. Burdelski, Christoph
   2. Menan, Devi
   3. Tsourlakis, Maria Christina
   4. Kluth, Martina
   5. Hube-Magg, Claudia
   6. Melling, Nathaniel
   7. Minner, Sarah

   2015 - Forschungsinformationssystem des UKE - frei zugänglich
8. VEGFR-1 overexpression identifies a small subgroup of aggressive prostate cancers in patients treated by prostatectomy

   1. Tsourlakis, Maria Christina
   2. Khosrawi, Puya
   3. Weigand, Philipp
   4. Kluth, Martina
   5. Hube-Magg, Claudia
   6. Minner, Sarah
   7. Koop, Christina

   2015 - Forschungsinformationssystem des UKE - frei zugänglich
9. Cytoplasmic Accumulation of Sequestosome 1 (p62) Is a Predictor of Biochemical Recurrence, Rapid Tumor Cell Proliferation, and Genomic Instability in Prostate Cancer

   1. Burdelski, Christoph
   2. Reiswich, V.
   3. Hube-Magg, Claudia
   4. Kluth, Martina
   5. Minner, Sarah
   6. Koop, Christina
   7. Graefen, Markus

   2015 - Forschungsinformationssystem des UKE
10. Overexpression of enhancer of zeste homolog 2 (EZH2) characterizes an aggressive subset of prostate cancers and predicts patient prognosis independently from pre- and postoperatively assessed clinicopathological parameters

    1. Melling, Nathaniel
    2. Thomsen, Erik
    3. Tsourlakis, Maria Christina
    4. Kluth, Martina
    5. Hube-Magg, Claudia
    6. Minner, Sarah
    7. Koop, Christina

    2015 - Forschungsinformationssystem des UKE
11. Overexpression of thymidylate synthase (TYMS) is associated with aggressive tumor features and early PSA recurrence in prostate cancer

    1. Burdelski, Christoph
    2. Strauss, Christian
    3. Tsourlakis, Maria Christina
    4. Kluth, Martina
    5. Hube-Magg, Claudia
    6. Melling, Nathaniel
    7. Lebok, Patrick

    2015 - Forschungsinformationssystem des UKE
12. Saccharomyces cerevisiae-like 1 overexpression is frequent in prostate cancer and has markedly different effects in Ets-related gene fusion-positive and fusion-negative cancers

    1. Burdelski, Christoph
    2. Barreau, Ysé
    3. Simon, Ronald
    4. Hube-Magg, Claudia
    5. Minner, Sarah
    6. Koop, Christina
    7. Graefen, Markus

    2015 - Forschungsinformationssystem des UKE
13. Loss of SOX9 Expression Is Associated with PSA Recurrence in ERG-Positive and PTEN Deleted Prostate Cancers

    1. Burdelski, Christoph
    2. Bujupi, Erzen
    3. Tsourlakis, Maria Christina
    4. Hube-Magg, Claudia
    5. Kluth, Martina
    6. Melling, Nathaniel
    7. Lebok, Patrick

    2015 - Forschungsinformationssystem des UKE - frei zugänglich
14. High nuclear karyopherin α 2 expression is a strong and independent predictor of biochemical recurrence in prostate cancer patients treated by radical prostatectomy

    1. Grupp, Katharina
    2. Habermann, Mareike
    3. Sirma, Hüseyin
    4. Simon, Ronald
    5. Steurer, Stefan
    6. Hube-Magg, Claudia
    7. Prien, Kristina

    2014 - Forschungsinformationssystem des UKE
15. High lysophosphatidylcholine acyltransferase 1 expression independently predicts high risk for biochemical recurrence in prostate cancers

    1. Grupp, Katharina
    2. Sanader, Stella
    3. Sirma, Hüseyin
    4. Simon, Ronald
    5. Koop, Christina
    6. Prien, Kristina
    7. Hube-Magg, Claudia

    2013 - Forschungsinformationssystem des UKE - frei zugänglich
16. Reduced CD147 expression is linked to ERG fusion-positive prostate cancers but lacks substantial impact on PSA recurrence in patients treated by radical prostatectomy

    1. Grupp, Katharina
    2. Höhne, Thorsten Simon
    3. Prien, Kristina
    4. Hube-Magg, Claudia
    5. Tsourlakis, Maria Christina
    6. Sirma, Hüseyin
    7. Pham, Taher

    2013 - Forschungsinformationssystem des UKE